Track Enveric Biosciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Enveric Biosciences, Inc. ENVB · Stock Open Enveric Biosciences, Inc. in new tab

1.52 USD
P/E
0.00
EPS
-13.01
P/B
0.73
ROE
-170.04
Beta
1.21
Loading chart...
Key Metrics
Earnings dateApril 1, 2027
P/E0.00
EPS-13.01
Book Value2.05
Price to Book0.73
Debt/Equity4.57
% Insiders8.893%
Estimates
Forward P/E-1.06
Forward EPS-1.41

DCF valuation

Model fair value for Enveric Biosciences, Inc. (ENVB)
Result
Sign in to run the valuation for ENVB.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Enveric Biosciences, Inc. Logo Enveric Biosciences, Inc. Analysis (ENVB)

United States Health Care Official Website Stock

Is Enveric Biosciences, Inc. a good investment? Enveric Biosciences, Inc. (ENVB) is currently trading at 1.52 USD.

In terms of valuation, the stock trades at a P/E ratio of 0.00. This relatively low multiple may signal that Enveric Biosciences, Inc. is undervalued compared to historical market norms.

Earnings Schedule: Enveric Biosciences, Inc. is expected to release its next earnings report on April 1, 2027. The market consensus estimate for Forward EPS is -1.41.

Investor FAQ

Does Enveric Biosciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Enveric Biosciences, Inc.?

Enveric Biosciences, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be April 1, 2027. The company currently has a trailing EPS of -13.01.

Company Profile

Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications. The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.

Exchange Ticker
NMS (United States) ENVB
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2008
0.02 USD
April 23, 2008 0.0210
Stock Splits
Split Date Split Ratio to 1
Dec. 17, 2008 1:10
May 26, 2015 0.0567891
Nov. 25, 2019 1:25
Dec. 31, 2020 1:4
July 15, 2022 1:50
Jan. 27, 2025 0.07
Oct. 28, 2025 1:12
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion